PFCS
CYT

Pale Fire Capital SE’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Pale Fire Capital SE’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-57,597
Closed -$175K – 84
2023
Q4 		$175K Hold
57,597
– – 0.03% 53
2023
Q3 		$164K Hold
57,597
– – 0.02% 43
2023
Q2 		$150K Buy
+57,597
New +$121K 0.01% 44

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Pale Fire Capital SE's CYT Position: Q1 2024 in Review

Pale Fire Capital SE sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 57,597 shares — an estimated $175K sold.

Pale Fire Capital SE first reported a position in CYT in Q2 2023 and held it in 3 quarters. The position peaked at $175K in Q4 2023. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

  • Pale Fire Capital SE reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Pale Fire Capital SE sold 57,597 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $175K.
  • Pale Fire Capital SE first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Pale Fire Capital SE's Cyteir Therapeutics, Inc. Common Stock position peaked at $175K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Pale Fire Capital SE's 13F filing for Q1 2024, filed 14 May 2024.